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Fig 2. Histologic and immunohistologic pictures of Langerhans cell histiocytosis. A, Histolog-
ically, tumor cells were medium-sized, with grooved or indented nuclei and abundant
eosinophilic cytoplasms. Moderate cellular pleomorphism was also a feature. Mitoses were not
exceptional, with absence of overtly atypical forms. B, Low-power view of the biopsy specimen
before treatment. C, Tumor cells were uniformly stained by the CD1a antibody, which also
highlighted epidermotropic tumor cells.D, After 3 weeks of vemurafenib treatment, the dermal
infiltrate had entirely disappeared, being replaced by mixed inflammatory cells. E, After
treatment, immunostaining for CD1a was restricted to skin-resident Langerhans cells. (A, B, and
D, Hematoxylin-eosin stain; original magnifications: A, 340; B, 32.5; D, 32.5. C and E, SABC;
original magnifications: C, 310; E, 35.)
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Extensive scleredema adultorum with loss of
eccrine glands
To the Editor: Scleredema adultorum is a disease
characterized by woody induration of the skin,1 in
which the skin appendages are usually preserved.
Here, we report a case of scleredema adultorumwith
loss of eccrine glands leading to frequent heat
strokes.
A 50-year-old Taiwanese woman visited us for
hardened and thickened skin extending from the
nape to the lower aspect of her back over the past 5Open access under CC BY-NC-ND license.years. Her back became anhidrotic and the front of
her trunk seemed hyperhidrotic. In the meantime,
she became progressively intolerant to heat and
experienced several episodes of heat strokes. She
refrained from outdoor activities to avoid heat
strokes. She had a 20-year history of type 2 diabetes
mellitus under insulin treatment over the past 10
years. She denied previous radiotherapy, topical
medications, toxin exposure, or family history of
similar skin changes. Neither photosensitivity nor
arthritis was present.
Examination revealed the skin from her nape to
the lower aspect of her back was hardened and
thickened, except the side aspects. The overlying
skin was slightly erythematous with preservation of
the hair follicles. Starch-iodine test showed the
lesional skin was anhidrotic (Fig 1). Her blood tests
were negative for antinuclear antibody, anti-Scl-70
antibody, and rheumatoid factor and pulmonary
function test result was within normal limits.
Fasting glucose level was 234 mg/dL and hemoglo-
bin A1c (HbA1c) was 9.6%.
Fig 1. Scleredema adultorum. Erythematous plaque
extending from her nape to the lower aspect of her back
(left) with anhidrosis on starch-iodine test (right).
Fig 2. Scleredema adultorum histopathology. A, Dermal
sclerosis with loss of eccrine glands and slight focal
lymphocytic infiltrate around hair follicles; B and C,
increased mucin deposition and decreased elastic fibers
(inset). (Hematoxylin-eosin stain; original magnification:
325. Inset, orcein [B] and alcian blue [C] stains; original
magnification: 340.)
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thickened dermis with increased collagen deposi-
tion, increased mucin, and decreased elastic fibers
(Fig 2). Direct immunofluorescence was negative for
IgG, IgA, IgM, complement component 3 (C3),
fibrinogen, and complement component 1, q sub-
component (C1q). Although scleromyxedema
cannot be ruled out by pathology findings, clinical
presentations and history above favored scleredemaadultorum associated with long-term diabetes.
Eccrine glands were absent in serial sections
(Fig 2), which explained her anhidrosis clinically.
Neither squamatization nor perieccrine inflamma-
tion was noted. She was treated with oral allopurinol
(100 mg/d).2 After 8-month follow-up, the erythema
and induration were slightly lessened, but the
anhidrosis persisted.
Scleredema adultorum is divided into 3
distinct types that are associated with preceding
infection, paraproteinemia, and diabetes mellitus,
respectively.1 In cases associated with infection, the
disease onset is more abrupt and the skin hardening
can usually regress. However, scleredema in diabetic
patients, like our case, progresses slowly and the
condition persists.
The association with loss of eccrine glands is a
distinct finding in our patient. Several diseases can
lead to hardened skin with loss of skin appendages,
including systemic sclerosis, lupus erythematosus,
radiotherapy, and chronic graft-versus-host dis-
ease.3-5 One hypothesis is that cells in the eccrine
glands are converted to myofibroblasts through
epithelial-mesenchymal transition and promote
fibrosis.4 There were no signs of autoimmune
diseases in this patient, such as Raynaud phenome-
non, dysphagia, myopathy, or difficulty breathing,
nor did the clinical presentation support such
diagnoses.
In reviewing 22 cases of scleredema adultorum at
our hospital from 2000 to 2012, we found no similar
changes of eccrine loss pathologically. How the
eccrine glands were lost in this case is unknown.
We noted a slight mononuclear infiltrate around the
preserved hair follicles histologically. The complete
loss of eccrine glands hinders further determination
of whether eccrine glands were destroyed by
preceding inflammatory infiltrate.
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Fig 1. Palifermin-associated papules. On the back of
patient’s forearms and hands were scattered 3- to 5-mm,
flesh-colored, flat-topped papules without scale.
Fig 2. Palifermin-associated papules. Slightly mamillated
epidermis with acanthosis, hypergranulosis, and mild
keratinocytic atypia of the basal and lower spinous layers.
(Hematoxylin-eosin stain; original magnification: 3100.)
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Papular eruption associated with palifermin
To the Editor: A 52-year-old man with nasal-type
extranodal natural killer T-cell lymphoma presented
with a 2-day history of scattered faintly erythematous
and skin-colored papules on the back of the neck
and bilateral upper extremities. He noted mild pru-
ritus associated with these lesions. Three days before
the eruption, the patient began treatment as an
inpatient with palifermin as mucositis prophylaxis
for chemotherapy and autologous stem cell
transplantation. Physical examination was notable
for scattered flat-topped erythematous papules on
the back of the neck, back of the hands, and
forearms (Fig 1). Examination of the oral mucosa
was unremarkable. A shave biopsy specimen
obtained from the back of the left hand (Fig 2)
revealed a slightly mamillated epidermis with
acanthosis, hypergranulosis, and mild keratinocytic
atypia of the basal and lower spinous layers.
The patient was given the diagnosis of a
palifermin-associated papular eruption and was
given triamcinolone acetonide for relief of pruritus.
Palifermin is a recombinant, N-truncated version
of human keratinocyte growth factor with similar
binding properties but increased stability. It is
Food and Drug Administration approved for
reducing the incidence and duration of severe
oral mucositis in patients with hematologic
malignancies receiving chemotherapy, radiotherapy,
and hematopoietic stem cell transplantation.1
Palifermin is administered intravenously at a doseof 60 g/kg/d for 3 consecutive days before radiation
therapy and 3 consecutive days after stem cell
transplantation.1 The average cost of palifermin
for a 70-kg patient is approximately $10,000.1
Adverse cutaneous reactions to palifermin in early
clinical trials were described as ‘‘rash,’’ ‘‘erythema,’’
or ‘‘pruritus’’ and were noted in 55%, 44%, and 50%
of treated patients, respectively.1,2 Other mucocuta-
neous reactions, including thickening and whitening
of the tongue, oral and flexural hyperpigmentation
or erythema, acanthosis nigricanselike eruptions,
palmoplantar erythrodysesthesia, and intertriginous
papular eruptions have since been described in the
literature.2-6
Our patient’s presentation most closely resembles
cases of flexural lichenoid or verruca planaelike
papular eruptions associated with palifermin.
One report describes a patient with multiple
myeloma who developed intertriginous erythema
and a papular eruption of the neck, trunk, and
extremities 1 day after completing a 3-day course
of palifermin.2 In situ hybridization to test for human
